Prashanth Prithviraj
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 4
- Pancreatic and Hepatic Oncology Research 4
-
- Renal and related cancers 3
- Co-authors
- Aparna Jayachandran (14 shared papers)Matthew Anaka (7 shared papers)George Kannourakis (9 shared papers)Jonathan Cebon (9 shared papers)Nuzhat Ahmed (3 shared papers)Andreas Behren (6 shared papers)Ritu Shrestha (5 shared papers)Kim R. Bridle (5 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)Oncotarget (3 papers)Journal of Clinical Medicine (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- AustraliaCanadaUnited Kingdom
In The Last Decade
Prashanth Prithviraj
27 papers receiving 742 citations
Peers
Comparison fields: 5 of 76
- Oncology 405
- Cancer Research 155
- Immunology 192
- Hepatology 55
- Pulmonary and Respiratory Medicine 193
Countries citing papers authored by Prashanth Prithviraj
This map shows the geographic impact of Prashanth Prithviraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashanth Prithviraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashanth Prithviraj more than expected).
Fields of papers citing papers by Prashanth Prithviraj
This network shows the impact of papers produced by Prashanth Prithviraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashanth Prithviraj. The network helps show where Prashanth Prithviraj may publish in the future.
Co-authors
The 25 scholars most cited alongside Prashanth Prithviraj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 110 | |
| 2 | 2014 | 108 | |
| 3 | 2018 | 103 | |
| 4 | 2016 | 92 | |
| 5 | 2020 | 77 | |
| 6 | 2016 | 41 | |
| 7 | 1988 | 35 | |
| 8 | 2015 | 33 | |
| 9 | 2016 | 28 | |
| 10 | 2021 | 27 | |
| 11 | 2022 | 18 | |
| 12 | 2021 | 15 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2015 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2015 | 5 | |
| 20 | 2018 | 3 |
About Prashanth Prithviraj
Prashanth Prithviraj is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 28 papers that have together received 753 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (4 papers), CAR-T cell therapy research (4 papers), Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Immunotherapy and Immune Responses (4 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Oncology (405 citations), Cancer Research (155 citations), Immunology (192 citations), Hepatology (55 citations) and Pulmonary and Respiratory Medicine (193 citations). Prashanth Prithviraj has collaborated with scholars based in Australia, Canada and United Kingdom. Frequent co-authors include Aparna Jayachandran, Matthew Anaka, George Kannourakis, Jonathan Cebon, Nuzhat Ahmed, Andreas Behren, Ritu Shrestha, Kim R. Bridle, Dorothy H. Crawford and Sonja J. McKeown. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncotarget, Journal of Clinical Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.